Dec. 3 at 1:24 AM
$WST Analysts expect strong future earnings from West Pharmaceutical Services (NYSE:WST) due to high-value product expansion, GLP-1 demand, and operational efficiencies. See why this
$350.77 price target could be achievable sooner than the market believes. https://biotechhealthx.com/biotech-news/west-pharmaceutical-services-wst-could-outperform-as-analysts-project-350-77-price-target/